41L Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Laboratorios Farmaceuticos ROVI SA

Watchlist Manager

Watchlist

Price: 53.85 EUR 0.75%

Market Cap: €2.9B

L	Laboratorios Farmaceuticos ROVI SA SWB:41L	ES
O	Orion Oyj XMUN:OFK	FI
	Aun Consulting Inc TSE:2459	JP
	Evonik Industries AG LSE:0QDS	DE
G	Games Workshop Group PLC F:G7W	UK

Profitability Summary

Laboratorios Farmaceuticos ROVI SA's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

65%

Strong 3Y Average Gross Margin

62%

Gross Margin is Increasing

62% > 65%

Healthy Operating Margin

25%

Sustainable 3Y Average Operating Margin

26%

Declining Operating Margin

29% > 25%

Healthy Net Margin

19%

Sustainable 3Y Average Net Margin

20%

Declining Net Margin

23% > 19%

Exceptional Free Cash Flow Margin

16%

Sustainable 3Y Average Free Cash Flow Margin

Free Cash Flow Margin is Increasing

5% > 16%

Positive ROE

23%

Exceptional 3Y Average ROE

Exceptional 3Y Average ROIC

28%

Declining ROIC

46% > 19%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.